Date published: 2025-10-25

1-800-457-3801

SCBT Portrait Logo
Seach Input

TMEM211 Inhibitors

LHFPL tetraspan subfamily member 7, designated as LHFPL7, belongs to the LHFPL family of proteins, which are characterized by their four hydrophobic transmembrane domains, making them part of the broader class of tetraspan transmembrane proteins. The LHFPL7 protein is encoded by the LHFPL7 gene located on chromosome 19 in humans.While detailed functional insights of LHFPL7 are not as extensively documented as those of some other tetraspan proteins, members of this family are generally implicated in a variety of cellular processes. These processes typically involve the modulation of cell signaling, trafficking of other membrane proteins, and contributing to the structure and maintenance of various cellular membranes.

LHFPL7, like its family members, is thought to play a role in the formation of complexes at cell membranes that are crucial for cell-to-cell communication and signal transduction. The tetraspan nature of LHFPL7 suggests a functional involvement in organizing the architecture of membrane domains, potentially influencing the assembly of signaling complexes or acting as scaffolds for receptor stabilization.Given the structural characteristics of tetraspanins, LHFPL7 may participate in the clustering of specific sets of proteins, such as receptors or ion channels, thereby influencing their functional properties. This could affect processes such as synaptic transmission or sensory perception, where precise membrane protein organization is critical.

SEE ALSO...

Items 1 to 10 of 11 total

Display:

Product NameCAS #Catalog #QUANTITYPriceCitationsRATING

Cycloheximide

66-81-9sc-3508B
sc-3508
sc-3508A
100 mg
1 g
5 g
$40.00
$82.00
$256.00
127
(5)

This compound inhibits protein synthesis in eukaryotic organisms, potentially reducing LHFPL7 protein levels.

Rapamycin

53123-88-9sc-3504
sc-3504A
sc-3504B
1 mg
5 mg
25 mg
$62.00
$155.00
$320.00
233
(4)

Rapamycin inhibits mTOR, a kinase involved in protein synthesis and cell growth, which may decrease LHFPL7.

Actinomycin D

50-76-0sc-200906
sc-200906A
sc-200906B
sc-200906C
sc-200906D
5 mg
25 mg
100 mg
1 g
10 g
$73.00
$238.00
$717.00
$2522.00
$21420.00
53
(3)

By binding to DNA, Actinomycin D inhibits RNA synthesis, which could lead to reduced LHFPL7 mRNA transcription.

Staurosporine

62996-74-1sc-3510
sc-3510A
sc-3510B
100 µg
1 mg
5 mg
$82.00
$150.00
$388.00
113
(4)

A kinase inhibitor that may downregulate signaling pathways involved in LHFPL7 expression.

Mitomycin C

50-07-7sc-3514A
sc-3514
sc-3514B
2 mg
5 mg
10 mg
$65.00
$99.00
$140.00
85
(5)

An antitumor antibiotic that can crosslink DNA, potentially decreasing LHFPL7 expression.

Fluorouracil

51-21-8sc-29060
sc-29060A
1 g
5 g
$36.00
$149.00
11
(1)

A pyrimidine analog that disrupts RNA processing and function, possibly reducing LHFPL7 expression.

Gefitinib

184475-35-2sc-202166
sc-202166A
sc-202166B
sc-202166C
100 mg
250 mg
1 g
5 g
$62.00
$112.00
$214.00
$342.00
74
(2)

By inhibiting EGFR tyrosine kinase, Gefitinib may impact signaling pathways regulating LHFPL7 expression.

Trichostatin A

58880-19-6sc-3511
sc-3511A
sc-3511B
sc-3511C
sc-3511D
1 mg
5 mg
10 mg
25 mg
50 mg
$149.00
$470.00
$620.00
$1199.00
$2090.00
33
(3)

TSA is an HDAC inhibitor that can alter gene expression, potentially affecting LHFPL7 levels.

α-Amanitin

23109-05-9sc-202440
sc-202440A
1 mg
5 mg
$260.00
$1029.00
26
(2)

This compound inhibits RNA polymerase II and could decrease LHFPL7 mRNA synthesis.

Bortezomib

179324-69-7sc-217785
sc-217785A
2.5 mg
25 mg
$132.00
$1064.00
115
(2)

A proteasome inhibitor that may affect protein turnover, indirectly impacting LHFPL7 stability.